JW0201
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for JW0201, covering 2025-09-09 to 2025-09-09. Get the full timeline:
Most recent: Clinical Trial Update: To Evaluate the Efficacy and Safety of JW0201 Added on in Patients With Type 2 Diabetes Mellitus [Phase 3]